This bacterium can also reduce the proliferation of CRC cells in organoid models via the conjugated use of PD-L1 blockade by increasing the proportion of CD8+ TILs and IFN-γ+ CD8+ lymphocytes and activating the STING pathway. Here, CD8A is linked to colorectal carcinoma.